New anti-tumor drug TR128 approved for clinical trial
TR128 capsule, a new drug for the treatment of advanced malignant solid tumors, has been approved by the National Medical Products Administration for clinical trials.
Dec 1, 2022
0
3
TR128 capsule, a new drug for the treatment of advanced malignant solid tumors, has been approved by the National Medical Products Administration for clinical trials.
Dec 1, 2022
0
3
A new research paper was published on the cover of Aging entitled "Glutaminase inhibitors rejuvenate human skin via clearance of senescent cells: a study using a mouse/human chimeric model."
Dec 1, 2022
0
28
Leprosy is one of the world's oldest and most persistent diseases but the bacteria that cause it may also have the surprising ability to grow and regenerate a vital organ.
Nov 15, 2022
0
169
As differently as cancers or autoimmune diseases (such as multiple sclerosis, rheumatoid arthritis or psoriasis) affect people, they all have one characteristic in common: they are accompanied by increased cell proliferation. ...
Nov 14, 2022
0
40
A diet of fresh fruits and vegetables may reduce the prevalence of cancers, including gastric cancer (GC). In addition, clinical studies have found that certain biologically active dietary molecules can inhibit multiple steps ...
Oct 28, 2022
0
26
Bipolar disorder, a neuropsychiatric condition that includes manic and depressive episodes, affects about 1% of the population and is strongly influenced by genetics. About half of patients respond very well to lithium salts ...
Oct 18, 2022
0
6
Research led by Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New Orleans' Schools of Medicine and Graduate Studies, reports a combination of a novel small inhibitory molecule and an FDA-approved chemotherapy ...
Oct 17, 2022
0
10
The oncogene EVI1 causes an aggressive type of leukemia, but its exact function has been a mystery. A research team led by scientists from Vienna now showed that EVI1's cancer causing effect relies on activating a single ...
Sep 20, 2022
0
71
Scientists at the UNC School of Medicine have made the surprising discovery that a molecule called EdU, which is commonly used in laboratory experiments to label DNA, is in fact recognized by human cells as DNA damage, triggering ...
Aug 23, 2022
0
160
An inflammatory signaling protein called interleukin-6 has been linked to the progression of acute myeloid leukemia, representing a potential target for future treatments of the disease, according to a recent Northwestern ...
Aug 16, 2022
0
6